WHO ICTRP trial
Half effective dose of remazolam combined with afentanil in the rapid reversible…
ChiCTR2300067371 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300067371 |
|---|---|
| Public title | Half effective dose of remazolam combined with afentanil in the rapid reversible induction of general anesthesia under the wrist and ankle needle |
| Scientific title | Half effective dose of remazolam combined with afentanil in the rapid reversible induction of general anesthesia under the wrist and ankle needle |
| Primary sponsor | Hebei Provincial Hospital of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Study on induction drugs of general anesthesia |
| Interventions | Group 1:Female group 18~65 years old: Stage I: wrist and ankle acupuncture + 0.3 mg/kg Remazolam + Afentanil (modified sequential administration) Phase II: wrist and ankle needle + Remazolam (modified sequential administration) + Afentanil… |
| Registration date | Jan 5, 2023 |
| Target size | Group 1:15;Group 2:15;Group 3:15;Group 4:15 |
| Secondary IDs | ChiMCTR2300006912 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: